Clinical Trial Update: A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults [Phase 2]

View source ↗

Summary

IPN10200 is being evaluated in a Phase 2 trial to prevent episodic and chronic migraine in adults, and the study is currently recruiting. The trial assesses saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• IPN10200

Snippet

Sponsor: Ipsen | Conditions: Episodic Migraine, Chronic Migraine | Phase 2 | Status: RECRUITING